{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:06:29Z","timestamp":1720137989694},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1038\/s41440-024-01676-w","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:04:12Z","timestamp":1713344652000},"page":"1952-1961","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of different treatment modalities on cardiovascular disease in ARR-positive hypertensive patients"],"prefix":"10.1038","volume":"47","author":[{"given":"Rui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"1676_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1676_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ecl.2019.08.003","volume":"48","author":"S Athimulam","year":"2019","unstructured":"Athimulam S, Lazik N, Bancos I. Low-Renin Hypertension. Endocrinol Metab Clin North Am. 2019;48:701\u201315.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1676_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","volume":"165","author":"BC Ruhle","year":"2019","unstructured":"Ruhle BC, White MG, Alsafran S, Kaplan EL, Angelos P, Grogan RH. Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery. 2019;165:221\u20137.","journal-title":"Surgery"},{"key":"1676_CR4","doi-asserted-by":"publisher","first-page":"798364","DOI":"10.3389\/fcvm.2021.798364","volume":"8","author":"X Lin","year":"2021","unstructured":"Lin X, Ullah MHE, Wu X, Xu F, Shan SK, Lei LM, et al. Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism. Front Cardiovasc Med. 2021;8:798364.","journal-title":"Front Cardiovasc Med"},{"key":"1676_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/joim.12831","volume":"285","author":"WJ Young","year":"2019","unstructured":"Young WJ. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126\u201348.","journal-title":"J Intern Med"},{"key":"1676_CR6","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab. 2006;91:3457\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"1676_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1676_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5694\/mja11.11468","volume":"197","author":"DW Johnson","year":"2012","unstructured":"Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust. 2012;197:224\u20135.","journal-title":"Med J Aust"},{"key":"1676_CR9","first-page":"188","volume":"32","author":"Adrenal Group of the Endocrinology Branch of the Chinese Medical Association","year":"2016","unstructured":"Adrenal Group of the Endocrinology Branch of the Chinese Medical Association. Expert consensus on the diagnosis and treatment of primary aldosteronism [J][J]. Chin J Endocrine Metabol. 2016;32:188\u201395.","journal-title":"Chin J Endocrine Metabol"},{"key":"1676_CR10","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice Committee.","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17\u2013S38.","journal-title":"Diabetes Care"},{"key":"1676_CR11","doi-asserted-by":"crossref","unstructured":"Vogt A, Weing\u00e4rtner O. Management of dyslipidaemias: The New 2019 ESC\/EAS-Guideline. Dtsch Med Wochenschr. 2021;146:75\u201384.","DOI":"10.1055\/a-1199-8193"},{"key":"1676_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99:559\u201369.","journal-title":"Kidney Int"},{"key":"1676_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","volume":"31","author":"X Sang","year":"2013","unstructured":"Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens. 2013;31:1465\u201371.","journal-title":"J Hypertens"},{"key":"1676_CR14","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary Aldosteronism in Patients in China With Recently Detected Hypertension. J Am Coll Cardiol. 2020;75:1913\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"1676_CR15","first-page":"267","volume":"51","author":"YM Li","year":"2020","unstructured":"Li YM, Ren Y, Chen T, Tian HM. Update and Research Progress in the Diagnosis of Primary Aldosteronism. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51:267\u201377.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"1676_CR16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1676_CR17","first-page":"300","volume":"9","author":"N Qian","year":"2022","unstructured":"Qian N, Xu J, Wang Y. Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis. J Cardiovasc Dev Dis. 2022;9:300.","journal-title":"J Cardiovasc Dev Dis"},{"key":"1676_CR18","doi-asserted-by":"publisher","first-page":"1148438405","DOI":"10.1177\/14703203211003781","volume":"22","author":"Y Jing","year":"2021","unstructured":"Jing Y, Liao K, Li R, Yang S, Song Y, He W, et al. Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis. J Renin Angiotensin Aldosterone Syst. 2021;22:1148438405.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1676_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.surg.2019.08.017","volume":"167","author":"YH Chang","year":"2020","unstructured":"Chang YH, Chung SD, Wu CH, Chueh JS, Chen L, Lin PC, et al. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism. Surgery. 2020;167:367\u201377.","journal-title":"Surgery"},{"key":"1676_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1676_CR21","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1161\/STROKEAHA.120.033990","volume":"52","author":"J McCarthy","year":"2021","unstructured":"McCarthy J, Yang J, Clissold B, Young MJ, Fuller PJ, Phan T. Hypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism. Stroke. 2021;52:e626\u201334.","journal-title":"Stroke"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01676-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T23:03:18Z","timestamp":1720134198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01676-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01676-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}